Structure Therapeutics, Inc. (GPCR)
49.40
+0.39
(+0.80%)
USD |
NASDAQ |
Aug 25, 14:41
Structure Therapeutics 1 Year Total Returns (Daily) : 149.9% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 149.9% |
| August 21, 2026 | 153.4% |
| August 20, 2026 | 172.1% |
| August 19, 2026 | 187.9% |
| August 18, 2026 | 168.2% |
| August 17, 2026 | 167.2% |
| August 14, 2026 | 194.2% |
| August 13, 2026 | 185.5% |
| August 12, 2026 | 187.7% |
| August 11, 2026 | 197.7% |
| August 10, 2026 | 229.9% |
| August 07, 2026 | 228.0% |
| August 06, 2026 | 222.6% |
| August 05, 2026 | 202.9% |
| August 04, 2026 | 195.8% |
| August 03, 2026 | 174.9% |
| July 31, 2026 | 169.9% |
| July 30, 2026 | 177.5% |
| July 29, 2026 | 166.0% |
| July 28, 2026 | 162.1% |
| July 27, 2026 | 171.4% |
| July 24, 2026 | 168.9% |
| July 23, 2026 | 179.7% |
| July 22, 2026 | 177.1% |
| July 21, 2026 | 172.2% |
| Date | Value |
|---|---|
| July 20, 2026 | 144.1% |
| July 17, 2026 | 148.2% |
| July 16, 2026 | 134.8% |
| July 15, 2026 | 158.0% |
| July 14, 2026 | 158.5% |
| July 13, 2026 | 171.6% |
| July 10, 2026 | 182.3% |
| July 09, 2026 | 188.7% |
| July 08, 2026 | 193.0% |
| July 07, 2026 | 202.3% |
| July 06, 2026 | 168.8% |
| July 02, 2026 | 161.5% |
| July 01, 2026 | 154.1% |
| June 30, 2026 | 158.8% |
| June 29, 2026 | 145.2% |
| June 26, 2026 | 135.8% |
| June 25, 2026 | 121.4% |
| June 24, 2026 | 115.2% |
| June 23, 2026 | 106.4% |
| June 22, 2026 | 109.4% |
| June 18, 2026 | 105.9% |
| June 17, 2026 | 114.6% |
| June 16, 2026 | 108.6% |
| June 15, 2026 | 98.66% |
| June 12, 2026 | 93.20% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Eli Lilly & Co. | 76.32% |
| Novo Nordisk A/S | -13.72% |
| Pfizer Inc. | 15.69% |
| Tarsus Pharmaceuticals, Inc. | 27.18% |
| Johnson & Johnson | 56.09% |